News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Photo from investor.agenusbio.com
Jun 28, 2024, 13:09

Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC

Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X:

“Impressive pathological response rate (71%, pCR 35%) with neoadjuvant BOT/BAL in MSS colorectal cancer from the update of NEST-1 trial.”

Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC

Source: Vittorio Studiale/X

Agenus Balstilimab BOT/BAL BOT/BAL immunotherapy botensilimab cancer colorectal cancer ESMO ESMOGI24 European Society for Medical Oncology Garo Armen Jennifer Buell Mehraneh Jafari metastatic MSS colorectal cancer MSS CRC neoadjuvant BOT/BAL NEST-1 trial OncoDaily Oncology Pashtoon Kasi Steven O'Day Vittorio Studiale
Special Coverage
Science
Aug 15, 2025, 09:19
Alireza Mansouri: A Study Shares Final Results of the NRG-CC003 Randomized Phase II/III Trial
Voices
Aug 15, 2025, 09:03
Harish Nagaraj: This Is Not Just Science. This Is Impact
Science
Aug 15, 2025, 08:43
Francesco Massari: Our First Translational Research from ARON-1α
Voices
Aug 15, 2025, 08:32
Yüksel Ürün: AI in Drug Discovery
Dialogues
Aug 15, 2025, 08:28
ONCOFFEE: Vera Megdanova on Oncology, Family, and the Challenges of Practicing Medicine in Bulgaria
Blog Posts
Aug 15, 2025, 08:03
Carmen Monge-Montero: Sometimes the Bravest Thing You Can Do is Ask for Help
Science
Aug 15, 2025, 07:31
Bishoy Morris Faltas: Paired Plus-Minus Sequencing for Accurate Dual-Strand DNA Analysis
Stories
Aug 15, 2025, 06:47
Oya Gilbert's Story Highlights Urgent Need to Protect NIH Research Funding - AACR
Science
Aug 15, 2025, 06:42
Denis Panizza: How Tight Can SBRT Prostate Margins Go?
Science
Aug 15, 2025, 06:33
Immune Youth in Old Age: Mayo Clinic Uncovers the Double-Edged Sword - E. Shyam P. Reddy
Voices
Aug 15, 2025, 06:32
Where AI Meets the Future of Cancer Research - NFCR
Insight
Aug 15, 2025, 06:24
Harpreet Singh: New Era for ADCs in HER-2 + Metastatic Breast Cancer